Report top-line data for Transpher A study
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 15 Nov 2021
- Due
- 30 Jun 2023
- Delivered
- November 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Pivotal Transpher A study top-line data readout expected between Q4 2022 and Q2 2023”
What we found
Evidence strength A What the grades mean
The company reported positive top-line data for the VIITAL study (formerly referred to as Transpher A) in November 2022, which is within the expected timeframe of Q4 2022 to Q2 2023.
-
A Abeona Therapeutics Inc. 8-K filed 2023-08-08
“The positive top-line data from the VIITAL study were reported in November 2022.” ✓ confirmed on the page
-
A Abeona Therapeutics Inc. 10-K filed 2024-03-18
“In November 2022, we announced positive topline data from our VIITAL™ study.” ✓ confirmed on the page
Market reaction: the shares moved +1.4% against the S&P 500 over the three sessions around the disclosure (7 Aug 2023 to 10 Aug 2023). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Transpher A top-line data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Abeona Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ABEO-003381 · Corrections policy